4//SEC Filing
Alexander Kristen 4
Accession 0001127602-24-007629
CIK 0001062822other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 4:33 PM ET
Size
15.7 KB
Accession
0001127602-24-007629
Insider Transaction Report
Form 4
Alexander Kristen
VP, Finance and Accounting
Transactions
- Exercise/Conversion
Common Stock
2024-02-28+2,700→ 33,050 total - Exercise/Conversion
Common Stock
2024-02-28+15,927→ 59,593 total - Exercise/Conversion
Restricted Stock Units
2024-02-28−2,700→ 0 total→ Common Stock (2,700 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−10,616→ 10,617 total→ Common Stock (10,616 underlying) - Exercise/Conversion
Restricted Stock Units
2024-02-28−15,927→ 31,853 total→ Common Stock (15,927 underlying) - Exercise/Conversion
Common Stock
2024-02-28+10,616→ 43,666 total - Tax Payment
Common Stock
2024-02-28$2.62/sh−11,793$30,898→ 47,800 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.
Documents
Issuer
LEXICON PHARMACEUTICALS, INC.
CIK 0001062822
Entity typeother
Related Parties
1- filerCIK 0001878867
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 4:33 PM ET
- Size
- 15.7 KB